Pharmacokinetic
Showing 26 - 50 of >10,000
Climacteric Syndrome, Menopause, Hypoestrogenism Trial in Santos (s.c 25 mg estradiol pellet)
Recruiting
- Climacteric Syndrome
- +2 more
- s.c 25 mg estradiol pellet
-
Santos, São Paulo, BrazilIrmandade Da Santa Casa De Misericórdia De Santos - Science Vall
Nov 13, 2023
Pharmacokinetic, Healthy, Drug Combination Trial in Bangkok (Artemether-lumefantrine, Amodiaquine, Artemether-lumefantrine +
Recruiting
- Pharmacokinetic
- +2 more
- Artemether-lumefantrine
- +2 more
-
Bangkok, ThailandFaculty of Tropical Medicine, Mahidol University
Nov 11, 2022
Ménière's Disease Trial in Munich (Betahistine diHCl, Selegiline-HCl)
Completed
- Ménière's Disease
- Betahistine dihydrochloride
- Selegiline-hydrochloride
-
Munich, Bavaria, GermanyDepartment of Neurology, Ludwig Maximilian University
Jul 10, 2023
Herbal Interaction Trial in Spokane (Kratom, Oxycodone)
Not yet recruiting
- Herbal Interaction
- Kratom
- Oxycodone
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Apr 26, 2023
Acute Pain, Lidocaine, Administration and Dosage Trial (Blood samples to measure lidocaine levels)
Not yet recruiting
- Acute Pain
- +2 more
- Blood samples to measure lidocaine levels
- (no location specified)
Jan 9, 2023
Pharmacodynamic Models of Chronic Disease Therapeutics for
Recruiting
- Chronic Disease
- Smoking
- Smoking
- non-somking
-
Chongqing, ChinaYu Xian
Dec 18, 2022
Pharmacokinetic of Posaconazole in Critically Ill Patients
Completed
- Therapeutic Drug Monitoring
- Critical Illness
- Posaconazole Therapeutic Drug Monitoring
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Nov 6, 2022
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Hypertension Trial (CKD-341, D958)
Not yet recruiting
- Hypertension
- CKD-341, D958
- (no location specified)
Jun 18, 2023
Hyperammonemia Trial in Changchun (TNP-2092 capsules, TNP-2092 capsules)
Completed
- Hyperammonemia
- TNP-2092 placebo capsules
- TNP-2092 capsules
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Nov 13, 2023
Healthy Trial in Sao Paulo (Supplement administation)
Completed
- Healthy
- Supplement administation
-
Sao Paulo, BrazilSchool of Physical Education and Sport - USP
Mar 1, 2023
Healthy Volunteers Trial in Belfast (Pulze device with heated tobacco sticks (Product A), Pulze device with heated tobacco
Recruiting
- Healthy Volunteers
- Pulze device with heated tobacco sticks (Product A)
- +4 more
-
Belfast, United KingdomCelerion
Oct 19, 2023
Hypertension, Diabetes, Type 2 Trial in Seoul (THP-00101 (Dapagliflozin) 10mg, THP-00102 (Telmisartan) 80mg)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- THP-00101 (Dapagliflozin) 10mg
- THP-00102 (Telmisartan) 80mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Sep 25, 2023
Healthy Volunteers Trial in Newark (Bimatoprost Ophthalmic)
Not yet recruiting
- Healthy Volunteers
- Bimatoprost Ophthalmic
-
Newark, New JerseyBiotrial
Feb 6, 2023
Opioid Dependence, Alcohol Dependence Trial (Vivitrol Injectable Product, IVL3004)
Not yet recruiting
- Opioid Dependence
- Alcohol Dependence
- Vivitrol Injectable Product
- IVL3004
- (no location specified)
Nov 10, 2022
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Healthy Trial in Seoul (ID120040002, Compound-X, Placebo comparator)
Recruiting
- Healthy
- ID120040002
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 21, 2022
Toxicomania Trial (Blood sampling)
Not yet recruiting
- Toxicomania
- Blood sampling
- (no location specified)
Aug 4, 2022
Healthy Trial in New York (Cannabidiol)
Active, not recruiting
- Healthy
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 28, 2022
Healthy, Pharmacokinetic Trial in Bangkok (Regimen 1 (Oral primaquine), Regimen 2 (IV primaquine phosphate), Regimen 3 (IV
Not yet recruiting
- Healthy
- Pharmacokinetic
- Regimen 1 (Oral primaquine)
- +2 more
-
Bangkok, ThailandFaculty of Tropical Medicine, Mahidol University
Jul 5, 2023
Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)
Not yet recruiting
- Opioid Withdrawal (Disorder)
- Standard of Care with Lofexidine
- Standard of Care without Lofexidine
- (no location specified)
Sep 14, 2023
Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)
Active, not recruiting
- Drug Interaction
- Nitazoxanide
- "Nitazoxanide" and "atazanavir/ritonavir" separately
-
Ile-Ife, Osun, NigeriaObafemi Awolowo University
Jan 8, 2023